La metformina ha sido durante dcadas el tratamiento de primera lnea para la diabetes tipo 2, mientras que la tirzepatida representa una terapia ms reciente con mecanismos de accin distintos
Because no licensed SmPC exists for retatrutide, there is no formally confirmed list of adverse effects
A conversation, not a commitment
Waiting for pharmaceutical approval suits those who prefer traditional medical oversight, need insurance coverage for affordability, or have health conditions requiring professional management
Sodium-glucose cotransporter 2 inhibition for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
BPC-157 promotes healing prima rily by activating the VEGF re ceptor 2 (VEGFR2) pathway, whi ch stimulates angiogenesis (formation of new blood vessels ) and tissue repair